Heloise M. Leclair
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma.
Journal: Cell death discovery
Published: September 03, 2025
AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma.
Journal: Cell death discovery
Published: September 03, 2025
The AhR-SRC axis as a therapeutic vulnerability in BRAFi-resistant melanoma.
Journal: EMBO molecular medicine
Published: January 04, 2022
CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and resistance.
Journal: EMBO molecular medicine
Published: September 16, 2020
Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors.
Journal: International journal of molecular sciences
Published: June 02, 2020
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma.
Journal: Nature communications
Published: January 24, 2018
Pharmacological targeting of apelin impairs glioblastoma growth.
Journal: Brain : a journal of neurology
Published: January 25, 2017
The E3 ubiquitin ligase MARCH3 controls the endothelial barrier.
Journal: FEBS letters
Published: June 22, 2016
Desert Hedgehog/Patch2 Axis Contributes to Vascular Permeability and Angiogenesis in Glioblastoma.
Journal: Frontiers in pharmacology
Published: October 21, 2015
The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity.
Journal: Cell communication and signaling : CCS
Published: November 20, 2014
Control of CXCR2 activity through its ubiquitination on K327 residue.
Journal: BMC cell biology
Published: June 26, 2014
Last Updated: 09/26/2026